Here's the 13-slide pitch deck ReCode Therapeutics used to raise $120 million from OrbiMed and Pfizer to develop new mRNA medicines · page 9 of 13
The slide uses bioluminescence imaging to demonstrate organ-specific targeting (selectivity) and expression levels (potency) across three different species.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 8/10
callout 0/1 image 3/3 list 3/3 metric 0/1 paragraph 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 10
callout infographic infographic infographic bullet bullet bullet primary paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.